Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

NCT00176059 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Renal Failure, Chronic
Renal Transplantation

Interventions

DRUG: intravenous immunoglobulins (IVIG)
PROCEDURE: kidney transplantation

Sponsor

University of Giessen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]